Wednesday 14 October 2026
Export OSCR’s income statement to Excel — free account
Oscar Health, Inc.
OSCR Healthcare Healthcare Plans
Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024. In the quarter to June 2026, revenue grew 70.4%, EPS grew 234.8%, free cash flow grew 316.3% and total debt rose 43.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
33.79
0.22
−0.65%
Follow OSCR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 16.68 |
P/S ratio |
0.43 | 0.32 | 0.26 | 0.56 | |
P/FCF ratio |
6.67 | 3.56 | 1.22 | 1.97 | |
P/Operating CF |
(5.09) | 5.61 | 1.31 | 4.12 | |
P/B ratio |
4.78 | 3.84 | 2.05 | 4.19 | |
Price to Tangible BV |
4.78 | 3.84 | 2.05 | 4.19 | |
EV/Sales |
0.31 | 0.12 | (0.07) | 0.32 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 7.87 | |
EV/Operating CF |
4.48 | 1.30 | (0.34) | 1.13 | |
EV/FCF |
4.68 | 1.35 | (0.34) | 1.14 | |
Quick Ratio |
0.69 | 0.72 | 0.83 | 0.57 | |
Current Ratio |
0.69 | 0.72 | 0.83 | 0.57 | |
Net Debt/EBITDA |
11.34 | 7.07 | (6.20) | (9.40) | |
Debt/Assets |
11.94% | 6.80% | 4.64% | 3.84% | |
Debt/Equity |
0.67 | 0.44 | 0.26 | 0.21 | |
Asset Turnover |
2.21 | 2.10 | 1.76 | 1.74 | |
Operating CF/Net income |
7.02 | (1.91) | 3.86 | 5.78 | |
Capex/Depreciation |
(30.22) | (4.51) | (9.20) | 11.43 | |
Interest Coverage |
(18.85) | 304.24 | 130.80 | 82.53 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
17.47% | 18.22% | 15.20% | 14.16% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.69% | 0.64% | 0.34% | 0.42% | |
Graham Net Nets |
(0.41) | (0.52) | (0.55) | (0.50) | |
Graham Number |
0.00 | 0.00 | 0.00 | 16.18 | |
Earnings Yield |
(4.97%) | (10.86%) | (3.31%) | 6.00% | |
Free Cash Flow Yield |
14.99% | 28.07% | 81.84% | 50.82% | |
Revenue per Share |
11.52 | 10.69 | 15.59 | 16.15 | |
Operating CF per Share |
(3.72) | 2.56 | 8.78 | 6.92 | |
Capex per Share |
(0.03) | (0.03) | (0.03) | (0.04) | |
Free Cash Flow per Share |
(3.76) | 2.53 | 8.75 | 6.88 | |
Cash per Share |
8.29 | 10.57 | 16.11 | 13.49 | |
Shareholders Equity per Share |
3.96 | 3.74 | 5.59 | 6.80 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.96 | 3.74 | 5.59 | 6.80 | |
Free Cash Flow |
(973.66) | 662.84 | 2,610.19 | 2,080.58 | |
Working Capital |
(1,212.76) | (1,323.77) | (1,211.51) | (3,689.03) | |
Capital Expenditures |
(9.01) | (9.06) | (8.79) | (11.76) | |
Net Current Asset Value |
(2,031.94) | (1,972.06) | (1,865.75) | (4,338.63) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 7.90 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 322.51 | 13.69 | |
| Other line items | |||||
Average Receivables |
451.11 | 489.57 | 763.80 | 655.18 | |
Average Payables |
3,394.18 | 4,042.61 | 5,523.01 | 6,659.03 | |
Average Assets |
5,114.45 | 5,582.95 | 7,566.71 | 8,805.44 | |
Average Common Equity |
1,096.17 | 998.58 | 1,501.58 | 1,608.26 |
Columns are period end dates